EFFECTIVENESS AND SAFETY OF RESCUE MEDICAL THERAPY FOR CHILDREN DEVELOPING ACUTE SEVERE COLITIS AFTER INFLIXIMAB FAILURE (RESCUC): A MULTI-CENTER RETROSPECTIVE STUDY BY THE PORTO GROUP

Remicade (infliximab) - J&J

tofacitinib - Generic mfg.

cyclosporine - Generic mfg.

Jyseleca (filgotinib) - Gilead

Rinvoq (upadacitinib) - AbbVie

Giulia D'Arcangelo

Jun 21, 2026